Literature DB >> 26248358

New Insights Regarding Yeast Survival following Exposure to Liposomal Amphotericin B.

Rita Teixeira-Santos1, Elisabete Ricardo2, Susana Gomes Guerreiro3, Sofia Costa-de-Oliveira2, Acácio Gonçalves Rodrigues4, Cidália Pina-Vaz5.   

Abstract

In vitro resistance to amphotericin B is an extremely rare event among pathogenic yeasts. However, in vivo response is sometimes reduced, resulting in an unfavorable outcome. Such adverse outcomes might be related to subfungicidal plasma concentrations. We aimed to clarify the mechanisms of liposomal amphotericin B (AMB-L; AmBisome)-induced lesions and the mechanisms responsible for yeast cell recovery following exposure at plasma concentrations. The physiological statuses developing following exposure to AMB-L at simulated plasma concentrations (20 to 0.1 mg/liter) and at a constant concentration (3 mg/liter) were assessed in a 24-h time course assay. Time-kill experiments also were carried out under the same AMB-L treatment conditions. Our results suggest that yeast cells develop compensatory responses related to membrane polarization, metabolic activity, and reactive oxygen species (ROS) production after exposure to high plasma concentrations (20 to 5 mg/liter) during the first 6 h; in the remaining 18 h, when exposed to lower concentrations, cells reveal almost full recovery with no evidence of fungicidal activity. In contrast, whenever cells are exposed to a constant concentration above the MIC, despite initially exhibiting compensatory stress responses, soon afterwards they exhibit membrane depolarization, a decrease of metabolic activity, increasing ROS production, and lastly, programmed cell death and necrosis, resulting in succumbing to AMB-L fungicidal effects. This study may represent a step forward in the support of AMB-L use for clinical treatment of invasive fungal infections, since it demonstrates the importance of maintaining levels of AMB-L above the MIC in plasma and tissues to ensure it produces its fungicidal effects.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26248358      PMCID: PMC4576075          DOI: 10.1128/AAC.00575-15

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  30 in total

1.  Assessment of the effect of amphotericin B on the vitality of Candida albicans.

Authors:  R S Liao; R P Rennie; J A Talbot
Journal:  Antimicrob Agents Chemother       Date:  1999-05       Impact factor: 5.191

2.  Treatment of Candida infections with amphotericin B lipid complex.

Authors:  James I Ito; Roya Hooshmand-Rad
Journal:  Clin Infect Dis       Date:  2005-05-01       Impact factor: 9.079

3.  Response of gene expression in Saccharomyces cerevisiae to amphotericin B and nystatin measured by microarrays.

Authors:  Liang Zhang; Yan Zhang; Yiming Zhou; Shuang An; Yuxiang Zhou; Jing Cheng
Journal:  J Antimicrob Chemother       Date:  2002-06       Impact factor: 5.790

4.  Safety, tolerance, and pharmacokinetics of a small unilamellar liposomal formulation of amphotericin B (AmBisome) in neutropenic patients.

Authors:  T J Walsh; V Yeldandi; M McEvoy; C Gonzalez; S Chanock; A Freifeld; N I Seibel; P O Whitcomb; P Jarosinski; G Boswell; I Bekersky; A Alak; D Buell; J Barret; W Wilson
Journal:  Antimicrob Agents Chemother       Date:  1998-09       Impact factor: 5.191

Review 5.  Effect of tissue penetration on AmBisome efficacy.

Authors:  Jill Adler-Moore; Richard T Proffitt
Journal:  Curr Opin Investig Drugs       Date:  2003-02

6.  Interactions of the drug amphotericin B with phospholipid membranes containing or not ergosterol: new insight into the role of ergosterol.

Authors:  J Milhaud; V Ponsinet; M Takashi; B Michels
Journal:  Biochim Biophys Acta       Date:  2002-02-01

7.  Comparison of caspofungin and amphotericin B for invasive candidiasis.

Authors:  Jorge Mora-Duarte; Robert Betts; Coleman Rotstein; Arnaldo Lopes Colombo; Luis Thompson-Moya; Juanita Smietana; Robert Lupinacci; Carole Sable; Nicholas Kartsonis; John Perfect
Journal:  N Engl J Med       Date:  2002-12-19       Impact factor: 91.245

8.  Sublethal injury and resuscitation of Candida albicans after amphotericin B treatment.

Authors:  Robert S Liao; Robert P Rennie; James A Talbot
Journal:  Antimicrob Agents Chemother       Date:  2003-04       Impact factor: 5.191

9.  Apoptosis induced by environmental stresses and amphotericin B in Candida albicans.

Authors:  Andrew J Phillips; Ian Sudbery; Mark Ramsdale
Journal:  Proc Natl Acad Sci U S A       Date:  2003-11-17       Impact factor: 11.205

10.  Characterization of uptake and hydrolysis of fluorescein diacetate and carboxyfluorescein diacetate by intracellular esterases in Saccharomyces cerevisiae, which result in accumulation of fluorescent product.

Authors:  P Breeuwer; J L Drocourt; N Bunschoten; M H Zwietering; F M Rombouts; T Abee
Journal:  Appl Environ Microbiol       Date:  1995-04       Impact factor: 4.792

View more
  3 in total

1.  Increasing the Fungicidal Action of Amphotericin B by Inhibiting the Nitric Oxide-Dependent Tolerance Pathway.

Authors:  Kim Vriens; Phalguni Tewari Kumar; Caroline Struyfs; Tanne L Cools; Pieter Spincemaille; Tadej Kokalj; Belém Sampaio-Marques; Paula Ludovico; Jeroen Lammertyn; Bruno P A Cammue; Karin Thevissen
Journal:  Oxid Med Cell Longev       Date:  2017-10-10       Impact factor: 6.543

2.  Evaluation of Physiological Effects Induced by Manuka Honey Upon Staphylococcus aureus and Escherichia coli.

Authors:  Patricia Combarros-Fuertes; Leticia M Estevinho; Rita Teixeira-Santos; Acácio G Rodrigues; Cidália Pina-Vaz; Jose M Fresno; M Eugenia Tornadijo
Journal:  Microorganisms       Date:  2019-08-13

3.  Unveiling the Synergistic Interaction Between Liposomal Amphotericin B and Colistin.

Authors:  Rita Teixeira-Santos; Elisabete Ricardo; Ricardo J Branco; Maria M Azevedo; Acácio G Rodrigues; Cidália Pina-Vaz
Journal:  Front Microbiol       Date:  2016-09-13       Impact factor: 5.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.